The SfN annual meeting continues to be an amazing opportunity for researchers around the world to come together to share and discuss their ideas driving innovative neuroscience research. This year, 22,359 attendees, 17,692 of which were scientists, made their way to Chicago for 5 days of presentations, networking, booth discussions, and everything in between at
Fostering Discussions and Discoveries at Neuroscience 2024 Read More »
Alzheimer’s disease is the leading neurological aging disorder impacting the lives of nearly 7 million Americans and 55 million individuals around the world. Alzheimer’s is the most common form of dementia, which is a general term for changes in cognitive abilities that interfere with daily life, such as memory loss. This disease is progressive, starting
Advancing Alzheimer’s Neurotherapeutics with Inscopix Miniscopes Read More »
Parkinson’s disease (PD) is a neurological disorder that affects 6 hundred thousand to more than 1 million people in the United States, or over 6 million worldwide, making it the second most prevalent brain disease behind Alzheimer’s. This disease presents differently in every individual but is typically marked by motor symptoms such as resting tremors,
From behavioral studies on learning and memory to sleep-wakefulness, 2023 was a year full of researchers uncovering interesting insights into the brain using Inscopix miniscopes. Did you know that the Inscopix community is illuminating the neurons responsible for REM sleep or performing experiments on contextual fear conditioning and discovering breakthroughs for diseases like Alzheimer’s? These
Discover 6 Noteworthy Inscopix Miniscope Publications of 2023 Read More »
